These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 24653214)

  • 1. MIRAGE: the minimum information required for a glycomics experiment.
    York WS; Agravat S; Aoki-Kinoshita KF; McBride R; Campbell MP; Costello CE; Dell A; Feizi T; Haslam SM; Karlsson N; Khoo KH; Kolarich D; Liu Y; Novotny M; Packer NH; Paulson JC; Rapp E; Ranzinger R; Rudd PM; Smith DF; Struwe WB; Tiemeyer M; Wells L; Zaia J; Kettner C
    Glycobiology; 2014 May; 24(5):402-6. PubMed ID: 24653214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The minimum information required for a glycomics experiment (MIRAGE) project: improving the standards for reporting glycan microarray-based data.
    Liu Y; McBride R; Stoll M; Palma AS; Silva L; Agravat S; Aoki-Kinoshita KF; Campbell MP; Costello CE; Dell A; Haslam SM; Karlsson NG; Khoo KH; Kolarich D; Novotny MV; Packer NH; Ranzinger R; Rapp E; Rudd PM; Struwe WB; Tiemeyer M; Wells L; York WS; Zaia J; Kettner C; Paulson JC; Feizi T; Smith DF
    Glycobiology; 2017 Apr; 27(4):280-284. PubMed ID: 27993942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The minimum information required for a glycomics experiment (MIRAGE) project: improving the standards for reporting mass-spectrometry-based glycoanalytic data.
    Kolarich D; Rapp E; Struwe WB; Haslam SM; Zaia J; McBride R; Agravat S; Campbell MP; Kato M; Ranzinger R; Kettner C; York WS
    Mol Cell Proteomics; 2013 Apr; 12(4):991-5. PubMed ID: 23378518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The minimum information required for a glycomics experiment (MIRAGE) project: sample preparation guidelines for reliable reporting of glycomics datasets.
    Struwe WB; Agravat S; Aoki-Kinoshita KF; Campbell MP; Costello CE; Dell A; Ten Feizi ; Haslam SM; Karlsson NG; Khoo KH; Kolarich D; Liu Y; McBride R; Novotny MV; Packer NH; Paulson JC; Rapp E; Ranzinger R; Rudd PM; Smith DF; Tiemeyer M; Wells L; York WS; Zaia J; Kettner C
    Glycobiology; 2016 Sep; 26(9):907-910. PubMed ID: 27654115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The minimum information required for a glycomics experiment (MIRAGE): reporting guidelines for capillary electrophoresis.
    Lageveen-Kammeijer GSM; Rapp E; Chang D; Rudd PM; Kettner C; Zaia J
    Glycobiology; 2022 Jun; 32(7):580-587. PubMed ID: 35348694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The minimum information required for a glycomics experiment (MIRAGE) project: LC guidelines.
    Campbell MP; Abrahams JL; Rapp E; Struwe WB; Costello CE; Novotny M; Ranzinger R; York WS; Kolarich D; Rudd PM; Kettner C
    Glycobiology; 2019 May; 29(5):349-354. PubMed ID: 30778580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards a standardized bioinformatics infrastructure for N- and O-glycomics.
    Rojas-Macias MA; Mariethoz J; Andersson P; Jin C; Venkatakrishnan V; Aoki NP; Shinmachi D; Ashwood C; Madunic K; Zhang T; Miller RL; Horlacher O; Struwe WB; Watanabe Y; Okuda S; Levander F; Kolarich D; Rudd PM; Wuhrer M; Kettner C; Packer NH; Aoki-Kinoshita KF; Lisacek F; Karlsson NG
    Nat Commun; 2019 Jul; 10(1):3275. PubMed ID: 31332201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of analytical methods for profiling N- and O-linked glycans from cultured cell lines : HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study.
    Ito H; Kaji H; Togayachi A; Azadi P; Ishihara M; Geyer R; Galuska C; Geyer H; Kakehi K; Kinoshita M; Karlsson NG; Jin C; Kato K; Yagi H; Kondo S; Kawasaki N; Hashii N; Kolarich D; Stavenhagen K; Packer NH; Thaysen-Andersen M; Nakano M; Taniguchi N; Kurimoto A; Wada Y; Tajiri M; Yang P; Cao W; Li H; Rudd PM; Narimatsu H
    Glycoconj J; 2016 Jun; 33(3):405-415. PubMed ID: 26511985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GlycoPOST realizes FAIR principles for glycomics mass spectrometry data.
    Watanabe Y; Aoki-Kinoshita KF; Ishihama Y; Okuda S
    Nucleic Acids Res; 2021 Jan; 49(D1):D1523-D1528. PubMed ID: 33174597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of asparagine-linked glycan structure databases and their use.
    Gao HY
    J Am Soc Mass Spectrom; 2009 Sep; 20(9):1739-42. PubMed ID: 19556140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative O-glycomics based on improvement of the one-pot method for nonreductive O-glycan release and simultaneous stable isotope labeling with 1-(d
    Wang C; Zhang P; Jin W; Li L; Qiang S; Zhang Y; Huang L; Wang Z
    J Proteomics; 2017 Jan; 150():18-30. PubMed ID: 27585995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CarbArrayART: a new software tool for carbohydrate microarray data storage, processing, presentation, and reporting.
    Akune Y; Arpinar S; Silva LM; Palma AS; Tajadura-Ortega V; Aoki-Kinoshita KF; Ranzinger R; Liu Y; Feizi T
    Glycobiology; 2022 Jun; 32(7):552-555. PubMed ID: 35352122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Databases and Associated Tools for Glycomics and Glycoproteomics.
    Lisacek F; Mariethoz J; Alocci D; Rudd PM; Abrahams JL; Campbell MP; Packer NH; Ståhle J; Widmalm G; Mullen E; Adamczyk B; Rojas-Macias MA; Jin C; Karlsson NG
    Methods Mol Biol; 2017; 1503():235-264. PubMed ID: 27743371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automating mass spectrometry-based quantitative glycomics using aminoxy tandem mass tag reagents with SimGlycan.
    Meitei NS; Apte A; Snovida SI; Rogers JC; Saba J
    J Proteomics; 2015 Sep; 127(Pt A):211-22. PubMed ID: 26003531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GRITS Toolbox-a freely available software for processing, annotating and archiving glycomics mass spectrometry data.
    Weatherly DB; Arpinar FS; Porterfield M; Tiemeyer M; York WS; Ranzinger R
    Glycobiology; 2019 Jun; 29(6):452-460. PubMed ID: 30913289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatics in glycomics: glycan characterization with mass spectrometric data using SimGlycan.
    Apte A; Meitei NS
    Methods Mol Biol; 2010; 600():269-81. PubMed ID: 19882135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative versus absolute quantitation in disease glycomics.
    Moh ES; Thaysen-Andersen M; Packer NH
    Proteomics Clin Appl; 2015 Apr; 9(3-4):368-82. PubMed ID: 25684231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human disease glycomics: technology advances enabling protein glycosylation analysis - part 2.
    Everest-Dass AV; Moh ESX; Ashwood C; Shathili AMM; Packer NH
    Expert Rev Proteomics; 2018 Apr; 15(4):341-352. PubMed ID: 29521143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of methods for profiling O-glycosylation: Human Proteome Organisation Human Disease Glycomics/Proteome Initiative multi-institutional study of IgA1.
    Wada Y; Dell A; Haslam SM; Tissot B; Canis K; Azadi P; Bäckström M; Costello CE; Hansson GC; Hiki Y; Ishihara M; Ito H; Kakehi K; Karlsson N; Hayes CE; Kato K; Kawasaki N; Khoo KH; Kobayashi K; Kolarich D; Kondo A; Lebrilla C; Nakano M; Narimatsu H; Novak J; Novotny MV; Ohno E; Packer NH; Palaima E; Renfrow MB; Tajiri M; Thomsson KA; Yagi H; Yu SY; Taniguchi N
    Mol Cell Proteomics; 2010 Apr; 9(4):719-27. PubMed ID: 20038609
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.